
Fosun International Limited
0656.HKHKSEIndustrialsConglomerates
Latest quote
HK$5.32
+HK$0.055 · +1.04%
0656.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteFosun International Limited operates as a global conglomerate, concentrating its diverse activities within the health, lifestyle, wealth management, and advanced manufacturing sectors. Its reach extends across Mainland China, Portugal, and various international territories. The company's comprehensive business model is primarily organized into five distinct segments: Health: This division is dedicated to the research, development, production, distribution, and commercialization of pharmaceuticals, biopharmaceuticals, and other health-related products, complemented by medical and health management services. Happiness: Focused on consumer experiences, this segment manages and invests in businesses related to tourism, leisure, fashion, and broader lifestyle industries. Insurance: Encompasses both the operation of insurance services and strategic investments within the global insurance market. Asset Management: This segment specializes in asset management services and various market investment activities. Intelligent Manufacturing: Involves both direct operations and investment in advanced manufacturing processes, including the production of iron and steel ore. Furthermore, Fosun International engages in capital investment and management, real estate development, retail, and reinsurance. Its extensive operations also include the manufacturing and sale of iron and steel products, provision of banking and financial services, medical consultation, and digital solution delivery. Founded in 1992 and headquartered in Shanghai, China, Fosun International Limited is a subsidiary of Fosun Holdings Limited.
- Industry
- Conglomerates
- Sector
- Industrials
- Headquarters
- HK
- CEO
- Qiyu Chen
- Listed since
- Jul 16, 2007
- Employees
- 103,900
Market position
- Volume
- 0
- 0× average
- Average volume
- 10.41M
- Average daily volume
- Market cap
- 43.23B HKD
- Beta
- 0.47
- Market reference 1
Financials
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 173.43B HKD | 192.14B HKD | 198.2B HKD | 182.43B HKD | 161.29B HKD |
| Cost of goods sold | 125.59B HKD | 140.54B HKD | 147.4B HKD | 118.01B HKD | 105.64B HKD |
| Gross profit | 47.84B HKD | 51.6B HKD | 50.8B HKD | 47.31B HKD | 55.65B HKD |
| Research and development | 4.31B HKD | 4.16B HKD | — | 4.91B HKD | 4.19B HKD |
| Selling, general, and administrative | 44.37B HKD | 45.65B HKD | 49.31B HKD | 43.57B HKD | 50.49B HKD |
| Operating expenses | 48.68B HKD | 49.84B HKD | 54.21B HKD | 48.49B HKD | 54.68B HKD |
| Interest income | 6.98B HKD | 5.01B HKD | 2.42B HKD | 3.06B HKD | 4.66B HKD |
| Interest expense | 14.47B HKD | 12.73B HKD | 12.07B HKD | 10.47B HKD | 9.54B HKD |
| Depreciation and amortization | 11.24B HKD | 7.41B HKD | 10.56B HKD | 6.65B HKD | 5.8B HKD |
| Operating income | −842.76M HKD | 1.76B HKD | −3.41B HKD | −1.18B HKD | 967.25M HKD |
| Net income | −23.4B HKD | −4.35B HKD | 1.38B HKD | −831.8M HKD | 10.08B HKD |
Company facts updated Aug 25, 2026.
Earnings
- EPS beat rate
- 0%
- 0 beats, 10 misses, 0 met estimates
- Average EPS surprise
- -433.30%
- 10 comparable reports
- Latest EPS result
- -3.29
- Estimate 0.1 · Miss by 3386.43%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
0656.HK peers
Continue in GoAI
Research 0656.HKresearch.disclaimer





